Pelthos Therapeutics Statistics
NYSE: PTHSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
21.15+0.16 (+0.76%)
Market open · Delayed 15 min · as of Oct 8, 11:58 AM ET
Pelthos Therapeutics by the numbers
Pelthos Therapeutics has a market capitalization of $81.0 million based on 3.83M shares outstanding. With trailing EPS of $-27.53, Pelthos Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.8% below its 50-day average and 15.2% below its 200-day average.
Average daily trading volume is 59.15K shares, or about $1.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PTHS valuation vs. peer median
| Metric | PTHS | Peer median | Difference |
|---|---|---|---|
| Market cap | $80.97M | $78.90M | +3% |
| Avg. volume | 59.15K | 404.98K | -85% |
Peer median across 8 companies: CRDF, GRML, NMRA, CGTX, OKYO, ATRA, CSBR, KLRS.
Valuation
- Market cap
- $80.97M
- EPS (TTM)
- $-27.53
- Shares outstanding
- 3.83M
Price and trading
- Previous close
- 20.99
- Open
- 21.41
- Day range
- 21.01 – 22.95
- 52-week range
- 18.19 – 37.50
- 52-week change
- -24.47%
- Beta
- —
- Volume
- 27.37K
- Average volume
- 59.15K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 80.97M
- Forward Pe
- -3.72
- Eps
- -27.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 37.50
- Week52 Low
- 18.19
- Avg Volume
- 59,151.00
- Shares Outstanding
- 3.83M
- Ma50
- 24.54
- Ma200
- 24.94
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -43.60%
- Pct From52w Low
- 16.27%